Categorizing immune responders with fusion metrics and simulation for association to survival & progression free survival with immune response in HLA-A2+ patients with GBM from a phase 2 trial of dendritic cell (DC) immunotherapy (ICT-107).
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures
Part of the Medicine and Health Sciences Commons